Status:

TERMINATED

Non-Polymer-Based, Rapamycin-Eluting Stents to Prevent Restenosis

Lead Sponsor:

Translumina GmbH

Conditions:

Coronary Disease

Eligibility:

All Genders

18-85 years

Phase:

PHASE4

Brief Summary

The purpose of the study is to evaluate the effectively of coating of coronary stents with two different doses of rapamycin for the prevention of coronary vessel re-blockage

Detailed Description

In-stent restenosis remains the major problem limiting the efficacy of coronary stenting. Either sirolimus or paclitaxel drug-eluting stents have been demonstrated to decrease neointima proliferation ...

Eligibility Criteria

Inclusion

  • Age 18-85 years; Symptoms (stable or unstable angina) or signs of myocardial ischemia; Single de novo diagnosed lesion in a native coronary artery (50-99% DS); Lesion length 8 - 25 mm; Vessel diameter 2.25-3.75 mm; Written informed consent

Exclusion

  • Left main target lesion unprotected by a graft; Ostial and bifurcation target lesion; Severely calcified lesions; Thrombus in target lesion; Tortuosity or angulation of target vessel or lesion; Treatment of nontarget lesions in the same or a different coronary vessel during the index procedure; Contraindications to the study medications; Acute myocardial infarction (\< 48 h); Left ventricular ejection fraction \< 25%; Participation in another trial; Pregnancy or lack of protection against pregnancy during the study Coexisting conditions limiting the life expectancy to less 24 months or that could affect the compliance of patients with protocol; Serum creatinin \>2.0mg/dL; Hemorrhagic diathesis; Leukocyte count \<3500/ml\^3 Platelet count \<100.000/ml\^3

Key Trial Info

Start Date :

December 1 2004

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

February 1 2007

Estimated Enrollment :

333 Patients enrolled

Trial Details

Trial ID

NCT00152308

Start Date

December 1 2004

End Date

February 1 2007

Last Update

October 8 2020

Active Locations (10)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (10 locations)

1

St. Johanns Spital

Salzburg, Austria, 5020

2

Donauspital der Stadt Wien

Vienna, Austria, 1020

3

Allgemeines Krankenhaus Wien

Vienna, Austria, 1090

4

Wilhelminenspital der Stadt Wien

Vienna, Austria, 1160

Non-Polymer-Based, Rapamycin-Eluting Stents to Prevent Restenosis | DecenTrialz